Program Details
Information about medical programs provided by each healthcare institution, including treatment details, schedules, etc.,
- Kanto / Tokyo
- medical treatment
- cancer
Cancer Gene Therapy Package
We administer a vector containing cancer-suppressing genes or a vector incorporating siRNA to inhibit cancer-proliferation genes (gene therapy proteins) via intravenous drip every 1 to 4 weeks. This can be performed concurrently with standard treatments such as surgery, chemotherapy, and radiation therapy.
We administer a vector containing cancer-suppressing genes or a vector incorporating siRNA to inhibit cancer-proliferation genes (gene therapy proteins) via intravenous drip every 1 to 4 weeks. In the first cycle, gene therapy proteins are administered five times, each time with 8 units. In the second cycle, gene therapy proteins are administered five times, each time with 10 units. This type of gene therapy is applicable to various types of cancer, including pancreatic cancer, lung cancer, colorectal cancer, gallbladder cancer, breast cancer, and gastric cancer. Side effects are minimal. The director has experience with gene therapy in several hundred cancer patients, and depending on the type and stage of cancer, it has shown curative, remission, or life-extending effects. This treatment can be performed concurrently with standard treatments such as surgery, chemotherapy, and radiation therapy.
- Providing Medical Institution
-
GRAND ETERNITY Ginza Clinic
〒104-0061
10th Floor, Kirarito Ginza, 1-8-19, Ginza, Chuo-Ku, Tokyo
- Eligibility Criteria/Exclusions for Treatment
- Target Diseases・Disease Status：
Pancreatic cancer, lung cancer, colorectal cancer, gastric cancer, breast cancer, uterine cancer, bladder cancer, kidney cancer, liver cancer, and more